Lotus Award
The Pershing Square Lotus Award funds innovative, collaborative ovarian cancer research aimed at major advances in early detection and treatment.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): February 2027 (Letter of Intent deadline, projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years, inclusive of up to 10% indirect costs)
Summary: Supports bold, collaborative ovarian cancer research to catalyze transformative advances in early detection and treatment.
Key Information: Nomination by a qualified board member or prior awardee is required to apply.
Description
The Pershing Square Lotus Award funds high-risk, high-reward research in ovarian cancer, aiming to accelerate breakthroughs by supporting innovative projects and fostering interdisciplinary collaboration. The award seeks to attract both established ovarian cancer researchers and investigators from other cancer fields who can bring new perspectives to this underfunded area. Projects must demonstrate significant innovation and potential impact on ovarian cancer—especially in areas such as early detection, novel therapeutic approaches, and paradigm-shifting research. The initiative is part of a broader mission to improve outcomes for ovarian cancer patients by creating a culture of hope and progress.
